EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 139 filers reported holding EPIZYME INC in Q1 2021. The put-call ratio across all filers is 15.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $422,679 | -10.1% | 48,528 | +12.1% | 0.00% | 0.0% |
| Q4 2020 | $470,140 | -43.7% | 43,291 | -16.7% | 0.00% | -60.0% |
| Q2 2020 | $835,000 | -74.5% | 51,982 | -75.4% | 0.01% | -73.0% |
| Q1 2020 | $3,280,000 | -35.1% | 211,400 | +2.9% | 0.04% | -5.1% |
| Q4 2019 | $5,055,000 | +1489.6% | 205,500 | +565.5% | 0.04% | +1850.0% |
| Q3 2019 | $318,000 | -37.0% | 30,877 | -23.2% | 0.00% | -50.0% |
| Q2 2019 | $505,000 | +297.6% | 40,200 | +94.7% | 0.00% | +300.0% |
| Q4 2018 | $127,000 | – | 20,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |